The U.S. P2Y12 inhibitors market comprises products that help prevent blood clots by blocking the action of P2Y12 receptors on platelets. These inhibitors are primarily used to prevent thrombosis during and after percutaneous coronary interventions (PCI) like stenting. The market has witnessed significant growth over the years owing to the rising number of PCI procedures performed annually to...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian